ANI Pharmaceuticals, Inc. recalls
2 notices naming ANI Pharmaceuticals, Inc. as the recalling firm, since May 27, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
ANI Pharmaceuticals, Inc.: hydrOXYzine Hydrochloride Oral Solution
Hazard (FDA): Presence of foreign substance
FDAMedicines
ANI Pharmaceuticals, Inc.: Estradiol Gel
Hazard (FDA): Defective Container; packets were found to be either empty or partially full.
FDAMedicines